Pharmabiz6m
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea
Newron Pharmaceuticals S.p.A, a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, and Myung In Pharm Co. Ltd. (Myung In ...
Pharmabiz1h
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart: Tucson, Arizona Saturday, January 11, 2025, 15:00 Hrs ...
Pharmabiz2h
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology: Ingelheim Saturday, January 11, 2025, 14:00 Hrs [IST] Boehringer Ingelheim and Synaf ...
Pharmabiz2h
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market: Ireland Saturday, January 11, 2025, 13:30 Hrs [IST] Gaelic Laboratories, a Europea ...
Pharmabiz3h
Seven research leaders awarded prestigious NIHR award
The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...
Pharmabiz4h
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis: Spring House, Pennsylvania Saturday, January 11, 2025, 12:00 ...
Pharmabiz6h
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy: Tokyo Saturday, January 11, 2025, 10:00 Hrs [IST] Astellas Pharma In ...
Pharmabiz7h
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation: London, UK Saturday, January 11, 2025, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...
Pharmabiz8h
Dr D Ramanathan wins Dhanwanthari Award for his contributions to Ayurveda
Dr D Ramanathan, managing director of Sitaram Ayurveda Pharmacy, Thrissur and general secretary of the Ayurveda Medicine ...
Pharmabiz8h
IDMA plans extensive workshops on revised Schedule M to assist pharma MSMEs
IDMA plans extensive workshops on revised Schedule M to assist pharma MSMEs: Shardul Nautiyal, Mumbai Saturday, January 11, ...
Pharmabiz8h
EU looks at India as best option over China, reflecting potential shifts in trade dynamics
EU looks at India as best option over China, reflecting potential shifts in trade dynamics: Nandita Vijayasimha, Bengaluru Saturday, January 11, 2025, 08:00 Hrs [IST] The European ...
Pharmabiz8h
SMPMA urges govt to drop conditions mandated for extension of revised Schedule M implementation
SMPMA urges govt to drop conditions mandated for extension of revised Schedule M implementation: Gireesh Babu, New Delhi Saturday, January 11, 2025, 08:00 Hrs [IST] The Delhi-base ...